Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Adaptive Biotechnologies Corp (ADPT) since 2019 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Adaptive Biotechnologies Corp. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1478320.
Total stock buying since 2019: $15,244,000.
Total stock sales since 2019: $1,191,021,204.
Total stock option exercises since 2019: $36,672,527.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 2,345,234 | $19,039,812 | 1,818,901 | $11,382,947 |
| 2024 | 0 | $0 | 208,558 | $747,749 | 20,000 | $22,500 |
| 2023 | 0 | $0 | 371,811 | $3,040,391 | 302,289 | $1,197,659 |
| 2022 | 0 | $0 | 149,445 | $1,629,238 | 44,445 | $280,890 |
| 2021 | 0 | $0 | 2,680,192 | $137,995,448 | 1,682,742 | $12,377,740 |
| 2020 | 0 | $0 | 28,716,845 | $1,018,663,741 | 3,163,148 | $11,125,841 |
| 2019 | 762,200 | $15,244,000 | 335,000 | $9,904,825 | 375,000 | $284,950 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-07-20 | Robins Harlan S (Chief Scientific Officer) | Sale | 3,895 | 37.31 | 145,341 |
| 2021-07-20 | Robins Harlan S (Chief Scientific Officer) | Option Ex | 3,895 | 6.32 | 24,616 |
| 2021-07-19 | Palaniappan Jyoti (SVP, Diagnostics, T-Detect) | Sale | 651 | 36.12 | 23,514 |
| 2021-07-19 | Palaniappan Jyoti (SVP, Diagnostics, T-Detect) | Option Ex | 651 | 22.55 | 14,680 |
| 2021-07-19 | Robins Harlan S (Chief Scientific Officer) | Sale | 3,895 | 37.02 | 144,173 |
| 2021-07-19 | Robins Harlan S (Chief Scientific Officer) | Option Ex | 3,895 | 6.32 | 24,616 |
| 2021-07-14 | Griffin Michelle Renee (Director) | Sale | 2,500 | 36.80 | 92,000 |
| 2021-07-14 | Griffin Michelle Renee (Director) | Option Ex | 2,500 | 7.80 | 19,500 |
| 2021-07-12 | Robins Chad M (CEO and Chairman) | Sale | 1,501 | 38.24 | 57,398 |
| 2021-07-08 | Adams R Mark (Chief Operating Officer) | Sale | 2,254 | 36.30 | 81,820 |
| 2021-07-07 | Adams R Mark (Chief Operating Officer) | Sale | 871 | 39.42 | 34,334 |
| 2021-07-07 | Cohen Chad M (Chief Financial Officer) | Sale | 10,000 | 38.69 | 386,850 |
| 2021-07-07 | Cohen Chad M (Chief Financial Officer) | Option Ex | 10,000 | 6.55 | 65,500 |
| 2021-07-06 | Cohen Chad M (Chief Financial Officer) | Sale | 10,000 | 38.83 | 388,300 |
| 2021-07-06 | Cohen Chad M (Chief Financial Officer) | Option Ex | 10,000 | 6.55 | 65,500 |
| 2021-06-18 | Palaniappan Jyoti (SVP, Diagnostics, T-Detect) | Sale | 1,301 | 39.80 | 51,779 |
| 2021-06-18 | Palaniappan Jyoti (SVP, Diagnostics, T-Detect) | Option Ex | 1,301 | 22.55 | 29,337 |
| 2021-06-17 | Adams R Mark (Chief Operating Officer) | Sale | 14,583 | 40.00 | 583,320 |
| 2021-06-17 | Adams R Mark (Chief Operating Officer) | Option Ex | 14,583 | 28.10 | 409,782 |
| 2021-06-17 | Palaniappan Jyoti (SVP, Diagnostics, T-Detect) | Sale | 651 | 40.00 | 26,040 |
| 2021-06-17 | Palaniappan Jyoti (SVP, Diagnostics, T-Detect) | Option Ex | 651 | 22.55 | 14,680 |
| 2021-06-17 | Taylor Stacy L (SVP and General Counsel) | Sale | 4,166 | 40.00 | 166,640 |
| 2021-06-17 | Taylor Stacy L (SVP and General Counsel) | Option Ex | 4,166 | 15.35 | 63,960 |
| 2021-06-17 | Robins Chad M (CEO and Chairman) | Sale | 5,255 | 39.16 | 205,759 |
| 2021-06-17 | Griffin Michelle Renee (Director) | Sale | 4,000 | 40.00 | 160,000 |
| 2021-06-17 | Griffin Michelle Renee (Director) | Option Ex | 4,000 | 7.80 | 31,200 |
| 2021-06-16 | Robins Chad M (CEO and Chairman) | Sale | 4,745 | 38.13 | 180,926 |
| 2021-06-15 | Robins Chad M (CEO and Chairman) | Sale | 20,000 | 38.73 | 774,500 |
| 2021-06-14 | Adams R Mark (Chief Operating Officer) | Sale | 8,914 | 38.77 | 345,595 |
| 2021-06-14 | Griffin Michelle Renee (Director) | Sale | 2,500 | 38.56 | 96,400 |
| 2021-06-14 | Griffin Michelle Renee (Director) | Option Ex | 2,500 | 7.80 | 19,500 |
| 2021-06-11 | Robins Harlan S (Chief Scientific Officer) | Sale | 3,895 | 38.41 | 149,606 |
| 2021-06-11 | Robins Harlan S (Chief Scientific Officer) | Option Ex | 3,895 | 6.32 | 24,616 |
| 2021-06-10 | Robins Harlan S (Chief Scientific Officer) | Sale | 3,895 | 37.32 | 145,361 |
| 2021-06-10 | Robins Harlan S (Chief Scientific Officer) | Option Ex | 3,895 | 6.32 | 24,616 |
| 2021-06-09 | Robins Harlan S (Chief Scientific Officer) | Sale | 3,895 | 36.20 | 141,018 |
| 2021-06-09 | Robins Harlan S (Chief Scientific Officer) | Option Ex | 3,895 | 6.32 | 24,616 |
| 2021-05-18 | Palaniappan Jyoti (SVP, Diagnostics, T-Detect) | Sale | 651 | 35.00 | 22,785 |
| 2021-05-18 | Palaniappan Jyoti (SVP, Diagnostics, T-Detect) | Option Ex | 651 | 22.55 | 14,680 |
| 2021-05-18 | Griffin Michelle Renee (Director) | Sale | 2,500 | 35.00 | 87,500 |
| 2021-05-18 | Griffin Michelle Renee (Director) | Option Ex | 2,500 | 7.80 | 19,500 |
| 2021-05-12 | Cohen Chad M (Chief Financial Officer) | Sale | 10,000 | 32.63 | 326,300 |
| 2021-05-12 | Cohen Chad M (Chief Financial Officer) | Option Ex | 10,000 | 6.55 | 65,500 |
| 2021-05-11 | Cohen Chad M (Chief Financial Officer) | Sale | 10,000 | 31.32 | 313,250 |
| 2021-05-11 | Cohen Chad M (Chief Financial Officer) | Option Ex | 10,000 | 6.55 | 65,500 |
| 2021-05-06 | Robins Harlan S (Chief Scientific Officer) | Sale | 3,895 | 35.95 | 140,005 |
| 2021-05-06 | Robins Harlan S (Chief Scientific Officer) | Option Ex | 3,895 | 6.32 | 24,616 |
| 2021-05-05 | Robins Harlan S (Chief Scientific Officer) | Sale | 3,195 | 35.43 | 113,198 |
| 2021-05-05 | Robins Harlan S (Chief Scientific Officer) | Option Ex | 3,895 | 6.32 | 24,616 |
| 2021-04-30 | Taylor Stacy L (SVP and General Counsel) | Sale | 4,166 | 41.93 | 174,680 |
| 2021-04-30 | Taylor Stacy L (SVP and General Counsel) | Option Ex | 4,166 | 15.35 | 63,960 |
| 2021-04-19 | Palaniappan Jyoti (SVP, Diagnostics, T-Detect) | Sale | 1,301 | 41.25 | 53,666 |
| 2021-04-19 | Palaniappan Jyoti (SVP, Diagnostics, T-Detect) | Option Ex | 1,301 | 22.55 | 29,337 |
| 2021-04-15 | Lo Francis (Chief People Officer) | Sale | 2,000 | 43.04 | 86,080 |
| 2021-04-15 | Lo Francis (Chief People Officer) | Option Ex | 2,000 | 7.80 | 15,600 |
| 2021-04-14 | Griffin Michelle Renee (Director) | Sale | 4,500 | 43.41 | 195,344 |
| 2021-04-14 | Griffin Michelle Renee (Director) | Option Ex | 4,500 | 7.80 | 35,100 |
| 2021-04-08 | Robins Chad M (CEO and Chairman) | Sale | 5,000 | 42.94 | 214,700 |
| 2021-04-07 | Adams R Mark (Chief Operating Officer) | Sale | 3,586 | 42.34 | 151,831 |
| 2021-04-07 | Robins Chad M (CEO and Chairman) | Sale | 5,000 | 41.03 | 205,150 |
| 2021-04-07 | Cohen Chad M (Chief Financial Officer) | Sale | 10,000 | 41.97 | 419,650 |
| 2021-04-07 | Cohen Chad M (Chief Financial Officer) | Option Ex | 10,000 | 6.32 | 63,200 |
| 2021-04-06 | Robins Chad M (CEO and Chairman) | Sale | 5,000 | 42.21 | 211,065 |
| 2021-04-06 | Cohen Chad M (Chief Financial Officer) | Sale | 10,000 | 40.95 | 409,500 |
| 2021-04-06 | Cohen Chad M (Chief Financial Officer) | Option Ex | 10,000 | 6.32 | 63,200 |
| 2021-03-31 | Taylor Stacy L (SVP and General Counsel) | Sale | 4,167 | 40.00 | 166,680 |
| 2021-03-31 | Taylor Stacy L (SVP and General Counsel) | Option Ex | 4,167 | 15.35 | 63,975 |
| 2021-03-25 | Robins Harlan S (Chief Scientific Officer) | Sale | 5,290 | 38.42 | 203,268 |
| 2021-03-25 | Robins Harlan S (Chief Scientific Officer) | Option Ex | 5,290 | 6.32 | 33,432 |
| 2021-03-24 | Robins Harlan S (Chief Scientific Officer) | Sale | 6,395 | 40.51 | 259,042 |
| 2021-03-24 | Robins Harlan S (Chief Scientific Officer) | Option Ex | 6,395 | 6.32 | 40,416 |
| 2021-03-23 | Robins Harlan S (Chief Scientific Officer) | Sale | 7,790 | 41.93 | 326,634 |
| 2021-03-23 | Robins Harlan S (Chief Scientific Officer) | Option Ex | 7,790 | 6.32 | 49,232 |
| 2021-03-19 | Robins Chad M (CEO and Chairman) | Sale | 5,000 | 42.22 | 211,100 |
| 2021-03-18 | Palaniappan Jyoti (SVP, Diagnostics, immunoSEQ Dx) | Sale | 16,052 | 44.06 | 707,299 |
| 2021-03-18 | Palaniappan Jyoti (SVP, Diagnostics, immunoSEQ Dx) | Option Ex | 16,052 | 22.55 | 361,972 |
| 2021-03-18 | Robins Chad M (CEO and Chairman) | Sale | 5,000 | 42.83 | 214,150 |
| 2021-03-17 | Robins Chad M (CEO and Chairman) | Sale | 5,000 | 44.17 | 220,835 |
| 2021-03-16 | Griffin Michelle Renee (Director) | Sale | 1,500 | 47.00 | 70,500 |
| 2021-03-16 | Griffin Michelle Renee (Director) | Option Ex | 1,500 | 7.80 | 11,700 |
| 2021-03-15 | Benzeno Sharon (Chief Business Development Officer) | Sale | 1,354 | 41.53 | 56,238 |
| 2021-03-15 | Benzeno Sharon (Chief Business Development Officer) | Option Ex | 1,354 | 31.71 | 42,935 |
| 2021-03-15 | Lo Francis (Chief People Officer) | Sale | 2,000 | 41.80 | 83,600 |
| 2021-03-15 | Lo Francis (Chief People Officer) | Option Ex | 2,000 | 7.80 | 15,600 |
| 2021-03-15 | Griffin Michelle Renee (Director) | Sale | 4,500 | 41.53 | 186,885 |
| 2021-03-15 | Griffin Michelle Renee (Director) | Option Ex | 4,500 | 7.80 | 35,100 |
| 2021-03-10 | Cohen Chad M (Chief Financial Officer) | Sale | 10,000 | 42.54 | 425,400 |
| 2021-03-10 | Cohen Chad M (Chief Financial Officer) | Option Ex | 10,000 | 6.32 | 63,200 |
| 2021-03-10 | Matrix Capital Management Company, Lp | Sale | 56,000 | 41.92 | 2,347,632 |
| 2021-03-09 | Cohen Chad M (Chief Financial Officer) | Sale | 10,000 | 40.41 | 404,050 |
| 2021-03-09 | Cohen Chad M (Chief Financial Officer) | Option Ex | 10,000 | 6.32 | 63,200 |
| 2021-03-09 | Matrix Capital Management Company, Lp | Sale | 250,000 | 40.79 | 10,198,000 |
| 2021-03-08 | Matrix Capital Management Company, Lp | Sale | 500,000 | 40.05 | 20,023,500 |
| 2021-03-08 | Hershberg Robert (Director) | Sale | 4,000 | 44.56 | 178,240 |
| 2021-03-08 | Hershberg Robert (Director) | Option Ex | 4,000 | .45 | 1,800 |
| 2021-03-01 | Benzeno Sharon (Chief Business Development Officer) | Sale | 6,771 | 57.87 | 391,837 |
| 2021-03-01 | Benzeno Sharon (Chief Business Development Officer) | Option Ex | 6,771 | 6.79 | 45,975 |
| 2021-03-01 | Rubinstein Julie (President) | Sale | 15,000 | 58.39 | 875,850 |
| 2021-03-01 | Rubinstein Julie (President) | Option Ex | 15,000 | 6.55 | 98,250 |
| 2021-03-01 | Pellini Michael J (Director) | Sale | 20,000 | 57.80 | 1,156,000 |
| 2021-03-01 | Pellini Michael J (Director) | Option Ex | 20,000 | 6.55 | 131,000 |
| 2021-02-26 | Taylor Stacy L (SVP and General Counsel) | Sale | 2,812 | 55.44 | 155,905 |
| 2021-02-26 | Taylor Stacy L (SVP and General Counsel) | Option Ex | 2,812 | 7.17 | 20,176 |
| 2021-02-26 | Rubinstein Julie (President) | Sale | 15,000 | 56.23 | 843,450 |
| 2021-02-26 | Rubinstein Julie (President) | Option Ex | 15,000 | 6.55 | 98,250 |
| 2021-02-25 | Rubinstein Julie (President) | Sale | 14,675 | 56.73 | 832,512 |
| 2021-02-25 | Rubinstein Julie (President) | Option Ex | 14,675 | 6.55 | 96,121 |
| 2021-02-24 | Rubinstein Julie (President) | Sale | 15,000 | 57.91 | 868,650 |
| 2021-02-24 | Rubinstein Julie (President) | Option Ex | 15,000 | 6.55 | 98,250 |
| 2021-02-23 | Rubinstein Julie (President) | Sale | 15,000 | 55.25 | 828,705 |
| 2021-02-23 | Rubinstein Julie (President) | Option Ex | 15,000 | 6.55 | 98,250 |
| 2021-02-22 | Rubinstein Julie (President) | Sale | 15,000 | 60.67 | 910,125 |
| 2021-02-22 | Rubinstein Julie (President) | Option Ex | 15,000 | 6.55 | 98,250 |
| 2021-02-19 | Benzeno Sharon (Chief Business Development Officer) | Sale | 416 | 61.20 | 25,459 |
| 2021-02-19 | Benzeno Sharon (Chief Business Development Officer) | Option Ex | 416 | 6.27 | 2,608 |
| 2021-02-19 | Rubinstein Julie (President) | Sale | 15,000 | 62.27 | 934,005 |
| 2021-02-19 | Rubinstein Julie (President) | Option Ex | 15,000 | 6.55 | 98,250 |
| 2021-02-18 | Rubinstein Julie (President) | Sale | 15,000 | 60.84 | 912,675 |
| 2021-02-18 | Rubinstein Julie (President) | Option Ex | 15,000 | 6.55 | 98,250 |
| 2021-02-17 | Rubinstein Julie (President) | Sale | 15,000 | 61.95 | 929,325 |
| 2021-02-17 | Rubinstein Julie (President) | Option Ex | 15,000 | 6.55 | 98,250 |
| 2021-02-16 | Taylor Stacy L (SVP and General Counsel) | Sale | 16,250 | 64.43 | 1,046,938 |
| 2021-02-16 | Taylor Stacy L (SVP and General Counsel) | Option Ex | 16,250 | 31.71 | 515,287 |
| 2021-02-16 | Benzeno Sharon (Chief Business Development Officer) | Sale | 16,250 | 64.43 | 1,047,036 |
| 2021-02-16 | Benzeno Sharon (Chief Business Development Officer) | Option Ex | 16,250 | 31.71 | 515,287 |
| 2021-02-16 | Rubinstein Julie (President) | Sale | 15,000 | 65.05 | 975,675 |
| 2021-02-16 | Rubinstein Julie (President) | Option Ex | 15,000 | 6.55 | 98,250 |
| 2021-02-16 | Lo Francis (Chief People Officer) | Sale | 2,000 | 65.45 | 130,900 |
| 2021-02-16 | Lo Francis (Chief People Officer) | Option Ex | 2,000 | 7.80 | 15,600 |
| 2021-02-16 | Hershberg Robert (Director) | Sale | 2,000 | 65.45 | 130,900 |
| 2021-02-16 | Hershberg Robert (Director) | Option Ex | 2,000 | .45 | 900 |
| 2021-02-16 | Griffin Michelle Renee (Director) | Sale | 6,000 | 65.08 | 390,480 |
| 2021-02-16 | Griffin Michelle Renee (Director) | Option Ex | 6,000 | 7.80 | 46,800 |
| 2021-02-12 | Rubinstein Julie (President) | Sale | 15,000 | 65.86 | 987,974 |
| 2021-02-12 | Rubinstein Julie (President) | Option Ex | 15,000 | 6.55 | 98,250 |
| 2021-02-11 | Rubinstein Julie (President) | Sale | 15,000 | 63.40 | 950,925 |
| 2021-02-11 | Rubinstein Julie (President) | Option Ex | 15,000 | 6.55 | 98,250 |
| 2021-02-10 | Rubinstein Julie (President) | Sale | 15,000 | 63.50 | 952,470 |
| 2021-02-10 | Rubinstein Julie (President) | Option Ex | 15,000 | 6.55 | 98,250 |
| 2021-02-10 | Robins Chad M (CEO and Chairman) | Sale | 10,000 | 62.90 | 628,970 |
| 2021-02-09 | Rubinstein Julie (President) | Sale | 15,000 | 62.41 | 936,225 |
| 2021-02-09 | Rubinstein Julie (President) | Option Ex | 15,000 | 6.43 | 96,525 |
| 2021-02-09 | Robins Chad M (CEO and Chairman) | Sale | 10,000 | 62.65 | 626,500 |
| 2021-02-08 | Rubinstein Julie (President) | Sale | 15,000 | 62.20 | 932,925 |
| 2021-02-08 | Rubinstein Julie (President) | Option Ex | 15,000 | 6.32 | 94,800 |
| 2021-02-08 | Robins Chad M (CEO and Chairman) | Sale | 10,000 | 61.80 | 618,000 |
| 2021-02-05 | Rubinstein Julie (President) | Sale | 15,000 | 59.88 | 898,200 |
| 2021-02-05 | Rubinstein Julie (President) | Option Ex | 15,000 | 6.32 | 94,800 |
| 2021-02-04 | Rubinstein Julie (President) | Sale | 15,000 | 59.01 | 885,150 |
| 2021-02-04 | Rubinstein Julie (President) | Option Ex | 15,000 | 6.32 | 94,800 |
Insider trading activities including stock purchases, stock sales, and option exercises of ADPT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Adaptive Biotechnologies Corp (symbol ADPT, CIK number 1478320) see the Securities and Exchange Commission (SEC) website.